New member
<H1>VIRACEPT</H1><P> VIRACEPT (nelfinavir mesylate) is an inhibitor of the human immunodeficiency
virus (HIV) protease. VIRACEPT Tablets are available for oral administration as a light
blue, capsule-shaped tablet with a clear film coating in 250 mg strength (as nelfinavir free
base) and as a white oval tablet with a clear film coating in 625 mg strength (as nelfinavir
free base). Each tablet contains the following common inactive ingredients: calcium
silicate, crospovidone, magnesium stearate, hypromellose, and triacetin. In addition, the
250 mg tablet contains FD&C blue #2 powder and the 625 mg tablet contains colloidal
silicon dioxide. VIRACEPT Oral Powder is available for oral administration in a
50 mg/g strength (as nelfinavir free base) in bottles. The oral powder also contains the
following inactive ingredients: microcrystalline cellulose, maltodextrin, dibasic
potassium phosphate, crospovidone, hypromellose, aspartame, sucrose palmitate, and
natural and artificial flavor. The chemical name for nelfinavir mesylate is [3S-[2(2S*,
3S*), 3,4a,8a]]-N-(1,1-dimethylethyl)decahydro-2-[2-hydroxy-3-[(3-hydroxy-2-
methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinoline carboxamide monomethanesulfonate
(salt) and the molecular weight is 663.90 (567.79 as the free base).</P>